Th e aim of this work was investigate the association of P catenin expression with the clinicopathologic features and prognosis of pancreatic carcinoma. RT-PCR was performed to investigate the expression of P catenin mRNA and western blotting were performed to investigate the expression of P catenin protein in  patients with pancreatic carcinoma. Th e relationships between P catenin expression and clinicopathological characteristics and prognosis were analyzed. Th e mRNA and protein expression of P catenin detected by RT-PCR and western blotting in pancreatic carcinoma was signifi cantly lower than that in normal pancreatic tissues (.±. vs .±., t=., P =.; .±. vs .±., t=., P=.). Reduced expression of P catenin mRNA and protein was signifi cantly correlated with lymph node metastasis (P =., P =.), vascular invasion (P =., P =. ), distant metastasis (P =. , P =.), diff erentiated (P =., P =.) and pTNM stage (P =., P =.) of tumours. Additionally, reduced expression of P catenin mRNA and protein in tumour correlated with a worse prognosis and normal expression with a better survival rate (P=., P=.). Th e reduced expression of both P catenin mRNA and protein in pancreatic carcinoma suggest that low expressions relate to pancreatic carcinoma development. P catenin may be related to pancreatic carcinoma behaviour and be a potential prognostic molecule.
Introduction
Pancreatic carcinoma is one of the most frequent causes of cancer-related death worldwide () . As it has aggressive behaviour and high metastatic potential, the mortality rate of patients with pancreatic carcinoma is high. Moreover, it is not responsive to chemotherapy or radiotherapy, and so the overall -year survival rate is less than  with median survival after diagnosis being approximately six months () . Th e identifi cation of a sensitive and representative disease marker is important for prognostication and as a guide for appropriate treatment. P catenin (Pctn) was fi rst identifi ed as a prominent tyrosine kinase substrate for Src, but has been also identifi ed to become tyrosine phosphorylated in response to receptor signaling through platelet-derived growth factor, colony-simulating factor-, and epidermal growth factor () . Pctn binds directly to cytoplasmic domain of E-cadherin which plays a key role in cell-cell interaction by armadillo- repeat domain (Arm domain), subsequently both of them constitute cadherin-catenin complex(CCC) () . It regulates E-cadherin turnover on the cell surface and its dissociation promotes E-cadherin internalization. It also stabilizes E-cadherin and rescues its function posttranslationally () . Besides cellular adhesive function, Pctn is also involved in the regulation of cell motility through actin cytoskeleton remodeling via Rho, Rac and Cdc GTPases () . Recently, altered expression and down-regulation of Pctn was reported to correlate with occurrence, development and prognosis of various cancers (-) . To date, however, there is no clinical trial verifying the relationship between Pctn and pancreatic carcinoma. In this study, expression of Pctn was investigated in pancreatic carcinoma tissues and control tissues using reverse transcriptase-polymerase chain reaction (RT-PCR) and western blotting. And the relationship of Pctn expression to the clinicopathological features and patient survival of pancreatic carcinoma was investigated.
Materials and Methods

Patients and tissue specimens
Excisional paired specimens of pancreatic carcinoma tissues and normal pancreas tissues were obtained from the department of General Surgery, Zhongda Hospital affi liated Southeast University between January  and January . Tumour specimens and paired normal pancreas tissues were obtained immediately after surgical resection, the normal pancreas tissues were taken more than mm away from the pancreatic carcinoma. Half of each tissue sample was immediately fi xed in  buffered formalin (Tianlong, Nanjing, China) and embedded in paraffi n. Section ( μm thick ) were prepared for haematoxylin and eosin (H.E.) (Dingtian, Shanghai, China) staining for histological diagnosis. Th e other half of the tissue was shape-frozen in liquid nitrogen and stored at - o C until used for RT-PCR or western blotting. Clinicopathological Data Detailed Clinicopathological characteristics including gender, age, serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA), tumour size, degree of differentiation, location of tumour, depth of invasion, vascular invasion, lymph node metastasis, distant metastasis and pTNM stage of patients were recorded ( Table ) . Staged according to the  tumour node metastasis (TNM) classification recommended by the international Union Against Cancer TNM classification (UICC). The study patients consisted of  patients in four TNM stages: stage I (n=), stage II (n=), stage III (n=) and stage IV (n=).
RT-PCR
Total RNA from specimens analyzed for P catenin expression was extracted using a commercial Kit (Gibco BRL, Paisley, UK). Total RNA (.μg) was reversetranscribed using the M-MLV Reverse Transcriptase (Zhongshan, Beijing, China) with incubation of  h at  o C, followed by  min at  o C ,and diluted to : with RNase-free water. RT-PCR was performed on complementary DNA samples using a DNA thermal cycler (Eppendorf Mastercycler gradient, Hamburg, Germany) with Reddymix PCR master mix (ABgene, Surrey, UK). DJ primers were constructed using the gene sequence obtained by BLAST search in the primer output program. Primer sequence was as follows: human Pctn
. Th e primer sequences were synthesized by Sangon Bioengineering Company (Shanghai, China). Conditions were as follow: Pctn-heating at  o C for  min, denaturation at  o C for  sec, annealing at  o C for  sec, extension at  o C for  sec, for  cycles; β-actinheating at  o C for  min, denaturation at  o C for  sec, annealing at  o C for  s, extension at  o C for  s, for  cycles; fi nial-extension at  o C for  min all of them. Products were separated on . agarose gels, isolated using the Invisorb Spin DNA extraction kit (Invitek GmbH, Berlin, Germany) and sequenced. Gels were photographed by the Kodak EDAS  system (Kodak, NY, USA). Densitometric analysis of films was performed using a computerized image analysis (NIH IM-AGE .) program.Pctn mRNA levels were established by calculating the target molecule/β-actin ratio (all cases scored for band intensity compared with control).
Western blotting
Pancreas tissues lysed with preparation of modified radioimmunoprecipitation buffer. Specimens were washed twice in TBS ( mmol/L Tris-HCl,  mmol/L NaCl, . Tween-) ( min each time) and after centrifugation at g for  min, the supernatant was extracted in bicinchoninic acid protein assay (Rockford, IL, USA). Th irty micrograms of protein sample was loaded onto a  SDS-PAGE and electroblotted onto a PVDF nylon membrane (Millipore, MA, USA). Membranes were blocked in TBS containing  skim milk, and then incubated with rabbit monoclonal Pctn antibodies (: dilution, No.P-UL, K, Sigma, USA) and rabbit polyclonal β-actin antibodies (Santa Cruz, CA, USA)at  o C overnight. Membranes were then incubated with a HRP-link goat anti-rabbit IgG secondary antibody (: dilution; Santa Cruz, CA, USA) at room temperature for  h. Finally, immunoteactive proteins were visualized on autoradipgram using ELC western blotting detection reagents (Amershan Pharmacia, Uppsala, Sweden) and exposed to X-Omat BT fi lm (Kodak, NY, USA).Bands were analyzed by Quantity One Analyses Software normalized with respect to β-actin as an internal control.
Statistical analysis
Statistical analyses were performed with SPSS software (Statistical Package for the Social Sciences, version ., SSPS, Inc., Chicago, IL). Continuous data were expressed as the mean+SD. Th e Student t-test and one-way analysis of variance (ANOVA) were used for continuous variables. For survival assessment, the Kaplan-Meier method with log-rank analysis was used. A P-value less than . was accepted as signifi cant for all calculations.
Results
Expression of Pctn mRNA in paired specimens of pancreatic carcinoma
Using reverse transcriptase-polymerase chain reaction analysis, we analysis the mRNA expression of Pctn. . agarose gels electrophoresis showed a bp Pctn fragment from pancreatic carcinoma and normal pancreas specimens ( Figure ) . Th e Pctn mRNA amplification were seen in all tissues. Th e transcript levels were .±. in tumour signifi cantly lower than that in normal pancreas tissues (.±., t=., P =.).
Expression of Pctn protein in paired specimens of pancreatic carcinoma
The affinity-purified anti-Pctn antibody detected a major band at ku in protein extracts from all specimens tested ( Figure . ), The expressions were .±. in tumour much lower than that in normal pancreas tissues (.±., t=., P=.) which was consistent with that of RT-PCR. R e l a t i o n s h i p b e t w e e n e x p r e s s i o n o f P    c t n p r o t e i n a n d c l i n i c o p a t h o l o g ical characteristics of pancreatic carcinoma. Relationship between expression of Pctn and clinicopathological characteristics of pancreatic carcinoma The correlation of Pctn mRNA and protein expression of Pctn protein with clinicopathological parameters was showed in Table. Statistical analysis showed the reduced expression of Pctn was significantly correlated with lymph node metastasis (P =. and P =.), vascular invasion (P =. and P =. ) and distant metastasis (P =. and P =. ).Th e expression of Pctn tended to be reduced in poorly-differentiated tumours compared with moderately-and well -differentiated tumours (P =. and P =.). In addition, the expression of Pctn was inversely associated with pTNM stage of tumours (P =. and P =.). But the correlation between the altered expression of Pctn and gender, age, serum CEA level, serum CA level, tumour size, location of tumour was not statistically signifi cant.
Relationship between Pctn expression and patient survival
Survival was assessed on the Pctn mRNA level and Pctn protein level separately by Kaplan-Meier analysis. When the value of Pctn/β-actin was lower than the mean, it was regarded as "reduced", others was regarded as "normal". patients had longer survivals compared with Pctn reduced patients ( log-rank test, t=., P=.) ( Figure  ). Th ere is a similar result on protein level. (log-rank test, t=., P=.) ( Figure . ).
Discussion
Th e Pctn belongs to a conserved family of armadillorelated proteins, many of which are associated with adherence junctions (β-catenin, plakoglobin). Th e human Pctn gene (CTNND) is located in chromosomes q and consists of  exons (-). Yanagisawa and Anastasiadis reported that Pctn joined in the course of cell motility and invasiveness which is important to the occurrence, and development of tumours, and Pctn may behave as a tumour suppressor (). Sarrio et al previously analyzed  breast carcinomas with respect to Pctn alterations and found absent or reduced Pctn expression in tumours () . In other studies, down-regulated expression of Pctn were also found in colon carcinoma, prostate carcinoma, esophageal squamous cell carcinoma, and lung carcinoma (-,) . In our study, we demonstrate that compared with the expression of Pctn in normal pancreatic tissues, it was signifi cantly lowered or even was not found in tumour tissues on the mRNA level. Th is is similar to results found on protein level. Pctn expression is down-regulated by genetic mechanisms in cancer. Pctn expression levels act as a master regulator or rheostat for overall E-cadherin which called a metastasis-suppressor gene () . Cadherins comprise a superfamily of transmembrane cell-cell adhesion receptors involved in a variety of biological processes including development, morphogenesis, and tumour metastasis. Cadherins on adjacent cells bind to one another through their extracellular domains. Th e intracellular domains mediate a re-organization of the actin cytoskeleton and promote intracellular signalling through interaction with the catenins (-) . Pctn interacts directly with the so-called juxtamembrane domain (JMD) and play signifi cant signaling roles in the nucleus, regulating cell proliferation and invasiveness () . As we all know, there are lots of growth factor receptor (GFR) including epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), transforming growth factor receptor-α (TGFR-α) in tumours. After being combined with the ligand, GFR enhance the degree of phosphorylation, and accelerate the phosphorylation of Pctn () . It may available to the reduction of Pctn expression on cellular membrane and cell junctions, consequently results in down-regulation of cell adhesion, up-regulation of cell migration. All of these may accelerate the invasion and metastasis of tumour. In previous study, we have reported that abnormal expression of Pctn was signifi cantly associated with expression of E-catering and VEGF in pancreatic carcinoma and three of them played an important role in the Wnt pathway which has been proved as a key fact of tumour aggressiveness () . So we have reason to say reduced expression of Pctn may induce the occurrence and development of pancreatic carcinoma. Besides the mechanism mediating the reduced Pctn expression, we found signifi cant association between its expression and clinicopathological parameters or survival. In our study, Pctn reduced expression in pancreatic carcinoma are signifi cant associated with tumour diff erentiation, lymph node metastasis, vascular invasion, distant metastasis and pTNM stage of tumours, indicating a correlation with biological aggressiveness. Moreover, Pctn expression was signifi cantly associated with patient survival, patients with reduced expression of Pctn were more likely to have disease progression or to die than those with normal expression of Pctn. Th ese data were in agreement with previous fi ndings demonstrating an altered expression of Pctn in tumours of breast, lung and prostate and a correlation with advanced stage, poorly differentiated and metastasis (-,) . Furthermore, Pctn has been reported as an independent prognostic marker in gastroesophageal adenocarcinoma () . One possibility is that Pctn absence from cells is tolerated in the context of the tumour microenvironment but not in vitro. Th us, signalling derived in vivo from tumour stroma or extracellular matrix may circumvent or substitute for a required Pctn function () . In vitro, such signals may be absent, such that cells explanted from Pctn-defi cient tumours fail to survive. Alternatively, the tumour microenvironment in vivo might actively suppress Pctn expression, and the suppressive mechanism could be lost when the cells are cultured in vitro. Th us, explanting Pctn-defi cient tumour tissue to the culture dish might restore Pctn expression. Th e resolution of these issues, and whether Pctn expression is modulated by the microenvironment during tumour progression and metastasis, may provide clinically useful information relevant to understanding and managing metastasis. Recent identification and characterization of a unique Pctn-defi cient carcinoma cell line has provided the first molecular clues as to potential consequences of Pctn loss in tumours (-) . SW cells are colon carcinoma cells with mutated Pctn genes and sharply reduced levels of Pctn protein, providing a rare opportunity to examine the consequences of Pctn loss and reconstitution in a tumour-derived cell line. Interestingly, the Pctn defi ciency appears to result in strongly reduced levels of E-cadherin, which in turn leads to loosely organized cells that fail to maintain epithelial morphology (-) . Restoring p rescues the epithelial phenotype, apparently by stabilizing and restoring normal levels of E-cadherin. Th us, it is possible that morphologic and behavioural changes in some tumours are due to Pctn loss and consequent destabilization of E-cadherin. All of these suggest that, Pctn down-regulation constitute an important parameter for the diagnosis of patients with respect to tumour aggressiveness.
Conclusion
In conclusion, reduced expression of Pctn mRNA and protein occurs frequently in pancreatic carcinoma, and is signifi cantly correlated with invasion and metastatic potentia of tumour. Furthermore, expression of Pctn may serve as a signifi cant prognostic factor for survival in pancreatic carcinoma. Th ese fi ndings strongly suggest that Pctn may be a novel molecular target for the diagnosis and treatment of pancreatic carcinoma.
